血小板フォスフォリパーゼ活性, トロンボキセンA2, および血中プロスタサイクリン生成に対する塩酸ジラゼップの効果

Saved in:
Bibliographic Details
Published in動脈硬化 Vol. 12; no. 4; pp. 1007 - 1012
Main Authors 鵜沢, 春生, 榊田, 典治, 竹田, 晴生, 矢野, 智彦, 岸川, 秀樹, 中村, 〓久, 清田, 敬
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本動脈硬化学会 01.10.1984
Online AccessGet full text
ISSN0386-2682
2185-8284
DOI10.5551/jat1973.12.4_1007

Cover

Author 竹田, 晴生
中村, 〓久
鵜沢, 春生
榊田, 典治
清田, 敬
矢野, 智彦
岸川, 秀樹
Author_xml – sequence: 1
  fullname: 鵜沢, 春生
  organization: 熊本大学医学部代謝内科学講座
– sequence: 1
  fullname: 榊田, 典治
  organization: 熊本大学医学部代謝内科学講座
– sequence: 1
  fullname: 竹田, 晴生
  organization: 熊本大学医学部代謝内科学講座
– sequence: 1
  fullname: 矢野, 智彦
  organization: 熊本大学医学部代謝内科学講座
– sequence: 1
  fullname: 岸川, 秀樹
  organization: 熊本大学医学部代謝内科学講座
– sequence: 1
  fullname: 中村, 〓久
  organization: 熊本大学医学部代謝内科学講座
– sequence: 1
  fullname: 清田, 敬
  organization: 熊本大学医学部代謝内科学講座
BookMark eNo9kMlKA0EQhhtRMC4P4M0HcGJ3zdKdo7iD4EXPQ0_s0QQ3kly8Od0IIR5UUERwQRBExQWiEDHow5QZ9S1sNXip-uH_6i_4e0jn6tqqImSA0azv-2y4KCssx90sg6wXMkp5B8kAE74jQHidJENdETgQCOgm_eVyIaKU5rgFIEPOPs83Ww876ckbmgPUV6if28Jco9lD00TdTB9f0s3LoUE0VTS3aOpojlHfon6xegSskdRQVzGp27T3hiUOfzgbpd9QP6G-QH3_G1j_2D9Lq7uY3LTuXzE5Qr3dOr_62mqgbqCx35tozM95cteqPaenx32kK5bLZdXf3r1kfmJ8bnTKmZmdnB4dmXGKQIV0APK-F4NyAahUcY77gQJYCJSIgogLJnggXMojCiynqBfIiHO1IGQcRa7Me7HbS8b-covlilxU4XqpsCJLG6EsVQr5ZRW2Kw4ZhF572J7_7fySLFnG_QZ9m64S
ContentType Journal Article
Copyright 一般社団法人 日本動脈硬化学会
Copyright_xml – notice: 一般社団法人 日本動脈硬化学会
DOI 10.5551/jat1973.12.4_1007
DeliveryMethod fulltext_linktorsrc
EISSN 2185-8284
EndPage 1012
ExternalDocumentID article_jat1973_12_4_12_4_1007_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
ID FETCH-LOGICAL-j208a-22c54f2e3220aef9756e22d6e8b6b7818768307b0219e046ab77ed8afbb3ac4f3
ISSN 0386-2682
IngestDate Wed Sep 03 06:28:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 4
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j208a-22c54f2e3220aef9756e22d6e8b6b7818768307b0219e046ab77ed8afbb3ac4f3
OpenAccessLink https://www.jstage.jst.go.jp/article/jat1973/12/4/12_4_1007/_article/-char/ja
PageCount 6
ParticipantIDs jstage_primary_article_jat1973_12_4_12_4_1007_article_char_ja
PublicationCentury 1900
PublicationDate 1984/10/01
PublicationDateYYYYMMDD 1984-10-01
PublicationDate_xml – month: 10
  year: 1984
  text: 1984/10/01
  day: 01
PublicationDecade 1980
PublicationTitle 動脈硬化
PublicationTitleAlternate 動脈硬化
PublicationYear 1984
Publisher 一般社団法人 日本動脈硬化学会
Publisher_xml – name: 一般社団法人 日本動脈硬化学会
References 10) Fujisawa, Y. and Abiko, Y.: Effect of dilazep on shape change of human erythrocyte in blood stored over a period of 42 days. Arzneim. -Forsch./Drug Res., 31: 1462-1468 (1981).
8) Sumiyoshi, A., Hayashi, T. and Fujii, M.: The inhibitory effect of dilazep on in vivo accumulation of platelets onto the damaged aorta in rabbit. Thrombos. Res., 23: 381-386 (1981).
17) Yorio, T. and Bentley, P. J.: Stimulation of active Na transport by phospholipase C. Nature, 261: 722-723 (1976).
18) Yorio, T., Torres, S. and Tarapoom, N.: Alteration in membrane permiability by diacylglycerol and phosphatidylcholine containing arachidonic acid. Lipids, 18: 96-99 (1983).
27) Fox, A. C., Reed, G. E., Glassman, E., Kaltman, A. J. and Silk, B. B.: Release of adenosine from human hearts during angina induced by rapid atrial pacing. J. Clin. Invest., 53: 1447-1457 (1974).
6) 鈴木ひとみ, 安井昭二, 大沼沖雄, 宮沢光瑞: 虚血性心疾患におけるDilazep内服の血小板凝集抑制効果. 薬理と治療, 10: 2175-2179 (1982).
11) Fujita, S., Ishida, Y., Izumi, K., Moritoki, H., Ohara, M. and Takei, M.: Potentiation by dilazep of the negative inotropic effect of adenosine on guinea-pig atria. Br. J. Pharmac., 68: 343-347 (1980).
15) Liu, M. S., Onji, T. and Snelgrove, N. E.: Changes in phase transition temperature of phospholipids induced by endotoxin. Biochim. Biophys. Acta, 710: 248-251 (1982).
9) 金是仁, 真柳佳昭, 佐野圭司: 血小板凝集抑制剤 (Aspirin, Dilazep) の血小板形態に及ぼす影響―走査電子顕微鏡による検討―. 医学のあゆみ, 112: 590-592 (1980).
4) 菅井浩二, 森和夫, 鈴木宗三, 阿久津保之, 酒井秀章, 佐々木睦郎: Dilazep (Comelian®) の血小板凝集およびATP放出に及ぼす影響―(1) ADP凝集―. 臨床と研究, 60: 3437-3442 (1983).
5) 古川賢一, 唐木重夫: Dilazepの血液凝固, 線溶能および血小板凝集, 粘着能に及ぼす影響 (第2報)―1回投与による作用の経時的観察―. 薬理と治療, 10: 1467-1471 (1982).
20) Salzman, E. W.: Prostaglandins and platelet function. Adv. Prostagl. Thrombox. Res., 2: 767-780 (1976).
19) Schoene, N. W. and Ianoco, J. M.: The influence of phospholipase A2 on prostaglandin production in platelets. Adv. Prostagl. Thrombox. Res., 2: 763-766 (1976).
23) 杉山理, 小沢高将, 宮崎豊, 永井修一郎: 塩酸ジラゼップによる虚血心筋ミトコンドリアの保護―ホスホリパーゼ抑制剤としての働き―. 薬理, 11: 3621-3626 (1983).
26) Schäumlöffel, E. and Prignitz, R.: Isotopentechnische Untersuchungen zur Pharmakokinetik und zum Metabolismus von Dilazep am Menschen. Arzneim.-Forsch., 22: 1651-1655 (1972).
22) Berlin, E., Shapiro, S. G. and Friedland, M.: Platelet membrane fluidity and aggregation of rabbit platelets. Atherosclerosis, 51: 223-239 (1984).
7) 戸山靖一, 野村裕, 山上徹, 鈴木恵子, 今岡真義: Dilazep長期投与による抗血小板作用. Progress in Medicine, 3: 455-460 (1983).
1) 中島勝明, 白井和良, 滝本正美, 佐藤文泰, 青木優典: 血小板凝集に及ぼすDilazepの影響. 基礎と臨床, 8: 146-150 (1974).
24) Takeda, H., Maeda, H., Fukushima, H., Nakamura, N. and Uzawa, H.: Increased platelet phospholipase activity in diabetic subjects. Thrombos. Res., 24: 131-141 (1981).
28) Haslam, R. J. and Rosson, G. M.: Effects of adenosine cyclic 3', 5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. Mol. Pharmacol., 11: 528-544 (1975).
29) Jacobs, K. H., Saur, W. and Johnson, R. A.: Regulation of platelet adenylate cyclase by adenosine. Biochim. Biophys. Acta, 583: 409-421 (1979).
13) 竹田晴生: ミトコンドリア膜とAdenine Nucleotide Translocator. 臨床病理, 29: 144-449 (1981).
2) Colli, S., Maderna, P., Morazzoni, G., Speroni, C. and Tremoli, E.: Effects of dilazep on human platelets and rat vascular tissue: In vitro studies on platelet aggregation, and arachidonic acid oxidation. Pharmacol. Res. Commun., 15: 593-602 (1983).
21) Ohki, K., Imai, A. and Nozawa, Y.: Aggregation induced alterations in human platelet membranes -A spin label study-. Biochem. Biophys. Res. Commun., 94: 1249-1255 (1980).
16) Liu, M. S., Ghosh, S. and Yang, Y.: Change in membrane lipid fluidity induced by phospholipase A activation: A mechanism of endotoxic shock. Life Sci., 33: 1995-2002 (1983).
12) Takeda, H. and Liu, M. S.: Effect of Escherichia Coli endotoxin on adenine nucleotide translocation in canine heart mitochondria. Arch. Biochem. Biophys., 204: 153-160 (1980).
25) Takeda, H., Yano, T., Kishikawa, H., Kobori, S. and Uzawa, H.: Relationship between platelet phospholipase activity and plasma in ischemic heart disease. Thrombos. Res., 34: 321-331 (1984).
30) 田村秀明, 白沢義〓, 堀平二, 近藤章市: 1, 4-Bis-[3-(3, 4, 5-trimethoxy benzoyl oxy)-propyl] perhydro-1, 4-diazepipne (Dilazep) の摘出平滑筋に対する作用について. 日薬理誌. 71: 757-768 (1975).
3) 安永幸二郎, 神崎光也, 木村征夫: Dilazep dihydro-chlorideの血小板凝集抑制作用. 内科宝函, 27: 99-107 (1980).
14) Liu, M. S. and Takeda, H.: Endotoxin-induced stimulation on phospholipase A activities in dog hearts. Biochem. Med., 28: 62-69 (1982).
References_xml – reference: 21) Ohki, K., Imai, A. and Nozawa, Y.: Aggregation induced alterations in human platelet membranes -A spin label study-. Biochem. Biophys. Res. Commun., 94: 1249-1255 (1980).
– reference: 15) Liu, M. S., Onji, T. and Snelgrove, N. E.: Changes in phase transition temperature of phospholipids induced by endotoxin. Biochim. Biophys. Acta, 710: 248-251 (1982).
– reference: 10) Fujisawa, Y. and Abiko, Y.: Effect of dilazep on shape change of human erythrocyte in blood stored over a period of 42 days. Arzneim. -Forsch./Drug Res., 31: 1462-1468 (1981).
– reference: 19) Schoene, N. W. and Ianoco, J. M.: The influence of phospholipase A2 on prostaglandin production in platelets. Adv. Prostagl. Thrombox. Res., 2: 763-766 (1976).
– reference: 30) 田村秀明, 白沢義〓, 堀平二, 近藤章市: 1, 4-Bis-[3-(3, 4, 5-trimethoxy benzoyl oxy)-propyl] perhydro-1, 4-diazepipne (Dilazep) の摘出平滑筋に対する作用について. 日薬理誌. 71: 757-768 (1975).
– reference: 1) 中島勝明, 白井和良, 滝本正美, 佐藤文泰, 青木優典: 血小板凝集に及ぼすDilazepの影響. 基礎と臨床, 8: 146-150 (1974).
– reference: 12) Takeda, H. and Liu, M. S.: Effect of Escherichia Coli endotoxin on adenine nucleotide translocation in canine heart mitochondria. Arch. Biochem. Biophys., 204: 153-160 (1980).
– reference: 20) Salzman, E. W.: Prostaglandins and platelet function. Adv. Prostagl. Thrombox. Res., 2: 767-780 (1976).
– reference: 6) 鈴木ひとみ, 安井昭二, 大沼沖雄, 宮沢光瑞: 虚血性心疾患におけるDilazep内服の血小板凝集抑制効果. 薬理と治療, 10: 2175-2179 (1982).
– reference: 25) Takeda, H., Yano, T., Kishikawa, H., Kobori, S. and Uzawa, H.: Relationship between platelet phospholipase activity and plasma in ischemic heart disease. Thrombos. Res., 34: 321-331 (1984).
– reference: 28) Haslam, R. J. and Rosson, G. M.: Effects of adenosine cyclic 3', 5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. Mol. Pharmacol., 11: 528-544 (1975).
– reference: 17) Yorio, T. and Bentley, P. J.: Stimulation of active Na transport by phospholipase C. Nature, 261: 722-723 (1976).
– reference: 23) 杉山理, 小沢高将, 宮崎豊, 永井修一郎: 塩酸ジラゼップによる虚血心筋ミトコンドリアの保護―ホスホリパーゼ抑制剤としての働き―. 薬理, 11: 3621-3626 (1983).
– reference: 7) 戸山靖一, 野村裕, 山上徹, 鈴木恵子, 今岡真義: Dilazep長期投与による抗血小板作用. Progress in Medicine, 3: 455-460 (1983).
– reference: 11) Fujita, S., Ishida, Y., Izumi, K., Moritoki, H., Ohara, M. and Takei, M.: Potentiation by dilazep of the negative inotropic effect of adenosine on guinea-pig atria. Br. J. Pharmac., 68: 343-347 (1980).
– reference: 3) 安永幸二郎, 神崎光也, 木村征夫: Dilazep dihydro-chlorideの血小板凝集抑制作用. 内科宝函, 27: 99-107 (1980).
– reference: 14) Liu, M. S. and Takeda, H.: Endotoxin-induced stimulation on phospholipase A activities in dog hearts. Biochem. Med., 28: 62-69 (1982).
– reference: 18) Yorio, T., Torres, S. and Tarapoom, N.: Alteration in membrane permiability by diacylglycerol and phosphatidylcholine containing arachidonic acid. Lipids, 18: 96-99 (1983).
– reference: 8) Sumiyoshi, A., Hayashi, T. and Fujii, M.: The inhibitory effect of dilazep on in vivo accumulation of platelets onto the damaged aorta in rabbit. Thrombos. Res., 23: 381-386 (1981).
– reference: 9) 金是仁, 真柳佳昭, 佐野圭司: 血小板凝集抑制剤 (Aspirin, Dilazep) の血小板形態に及ぼす影響―走査電子顕微鏡による検討―. 医学のあゆみ, 112: 590-592 (1980).
– reference: 29) Jacobs, K. H., Saur, W. and Johnson, R. A.: Regulation of platelet adenylate cyclase by adenosine. Biochim. Biophys. Acta, 583: 409-421 (1979).
– reference: 22) Berlin, E., Shapiro, S. G. and Friedland, M.: Platelet membrane fluidity and aggregation of rabbit platelets. Atherosclerosis, 51: 223-239 (1984).
– reference: 16) Liu, M. S., Ghosh, S. and Yang, Y.: Change in membrane lipid fluidity induced by phospholipase A activation: A mechanism of endotoxic shock. Life Sci., 33: 1995-2002 (1983).
– reference: 26) Schäumlöffel, E. and Prignitz, R.: Isotopentechnische Untersuchungen zur Pharmakokinetik und zum Metabolismus von Dilazep am Menschen. Arzneim.-Forsch., 22: 1651-1655 (1972).
– reference: 13) 竹田晴生: ミトコンドリア膜とAdenine Nucleotide Translocator. 臨床病理, 29: 144-449 (1981).
– reference: 27) Fox, A. C., Reed, G. E., Glassman, E., Kaltman, A. J. and Silk, B. B.: Release of adenosine from human hearts during angina induced by rapid atrial pacing. J. Clin. Invest., 53: 1447-1457 (1974).
– reference: 24) Takeda, H., Maeda, H., Fukushima, H., Nakamura, N. and Uzawa, H.: Increased platelet phospholipase activity in diabetic subjects. Thrombos. Res., 24: 131-141 (1981).
– reference: 4) 菅井浩二, 森和夫, 鈴木宗三, 阿久津保之, 酒井秀章, 佐々木睦郎: Dilazep (Comelian®) の血小板凝集およびATP放出に及ぼす影響―(1) ADP凝集―. 臨床と研究, 60: 3437-3442 (1983).
– reference: 2) Colli, S., Maderna, P., Morazzoni, G., Speroni, C. and Tremoli, E.: Effects of dilazep on human platelets and rat vascular tissue: In vitro studies on platelet aggregation, and arachidonic acid oxidation. Pharmacol. Res. Commun., 15: 593-602 (1983).
– reference: 5) 古川賢一, 唐木重夫: Dilazepの血液凝固, 線溶能および血小板凝集, 粘着能に及ぼす影響 (第2報)―1回投与による作用の経時的観察―. 薬理と治療, 10: 1467-1471 (1982).
SSID ssib000972182
ssj0003239275
ssib002821934
Score 1.312318
SourceID jstage
SourceType Publisher
StartPage 1007
Title 血小板フォスフォリパーゼ活性, トロンボキセンA2, および血中プロスタサイクリン生成に対する塩酸ジラゼップの効果
URI https://www.jstage.jst.go.jp/article/jat1973/12/4/12_4_1007/_article/-char/ja
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 動脈硬化, 1984/10/01, Vol.12(4), pp.1007-1012
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2185-8284
  dateEnd: 20021231
  omitProxy: true
  ssIdentifier: ssj0003239275
  issn: 0386-2682
  databaseCode: KQ8
  dateStart: 19730101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Na9RAFA-1XryIouI3PTg3t24mk8zMwUOy3VIUBaGF3pZkN3vooYq0F0_dBKHUgwqKCNVSEKRKrVCFlhb7x4y76v_gwfcmk2zWKlq9hMe8N-_j92aTednJjGVdcjllzdiLKnG72aowaYeViIpqJcJTzUM7pjTCF_o3bnoTU-zatDs9NPy9tGppfi4abd775Xcl_5JVaIO84leyB8hsoRQagIb8whUyDNe_yjGpC-LbuFih7pKgSsQ4qXtEjpEACIcIh0hXE5T40hCB_A3LIb6fs2xDBLW8Vw01B4wEARJg0eeYHSMnRK5iLO_p5LpyFYZFtQoj49NCCYThGwGjzdZKigjBtujrl3zQYhEYzYMHooiQ5cT4z6GiCU4kI1JjB6Zl1Vj3A4QVugR10yJzEyJj2Ro7SYSLvhmjBRSyhF2GkjPoPHSvox4IHJ2HzNUBrnK5oLmBTpUggmlkuLZb06wakcWbVXQEIpZZpiBWgy2oBdzcIsy-vEd8T6OuOTB-tLybh6O1BEFfniMk6OmAvIewwMjYr58jqOAGIsSJqJflfT1kx8CD_nsnWwpWrGDM7hQm7Zh_gdFj3BzzGWjkZEB8R3uajWeGigM_s8J11B4iYuD6A5I6p-iSVgQtfukx6QivQr3sCKvRWLfBvNXFDRLYwHOelu5nrPTQxoVCpQkg7nj3q8mFC8WFPtRizpbcwT8RWKPfdWDPdnNHaBjZhk0bzFxwi_CcjR9Wgswh6zCFOQkePHP9Vqk4wo21xMCaB6i2WPEG2aFQ2-idxAsIsmUb6OiVfW7CFHsGCs58saqeP08es46awnfEz5w6bg3NhCesla-rC933D3sv9lT6VCVrKtk2RPpGpY9VuquS3d6Hnd7C68sjKl1U6bpKN1W6rJJ1lewA7VNgdJZUsqg6m6Dt8xZIPEM5UJXsqeSjSl6pZEMr3PzyZKW3-Eh13nY3PqnOc5U86K6ufbu_pZItlYL1XZWm2L3zrru03Xu5fNKaGq9P1iYq5siYygytirBCadNlbRrDNKUaxm3JXQ8eNy0vFpEXcShOuCdgVhNBZSPjKvPCiPO4JcJ2FDlhk7WdU9bw7O3Z-LQ10m7ZnNseNMYui6UjuGx7bddp2tRu2XHzjHU1w7NxJ9sXqHGwrJ_9z_7nrCP9n-V5a3ju7nx8AQqkueiiHkc_AAxaLaU
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%A1%80%E5%B0%8F%E6%9D%BF%E3%83%95%E3%82%A9%E3%82%B9%E3%83%95%E3%82%A9%E3%83%AA%E3%83%91%E3%83%BC%E3%82%BC%E6%B4%BB%E6%80%A7%2C+%E3%83%88%E3%83%AD%E3%83%B3%E3%83%9C%E3%82%AD%E3%82%BB%E3%83%B3A2%2C+%E3%81%8A%E3%82%88%E3%81%B3%E8%A1%80%E4%B8%AD%E3%83%97%E3%83%AD%E3%82%B9%E3%82%BF%E3%82%B5%E3%82%A4%E3%82%AF%E3%83%AA%E3%83%B3%E7%94%9F%E6%88%90%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B%E5%A1%A9%E9%85%B8%E3%82%B8%E3%83%A9%E3%82%BC%E3%83%83%E3%83%97%E3%81%AE%E5%8A%B9%E6%9E%9C&rft.jtitle=%E5%8B%95%E8%84%88%E7%A1%AC%E5%8C%96&rft.au=%E9%B5%9C%E6%B2%A2%2C+%E6%98%A5%E7%94%9F&rft.au=%E6%A6%8A%E7%94%B0%2C+%E5%85%B8%E6%B2%BB&rft.au=%E7%AB%B9%E7%94%B0%2C+%E6%99%B4%E7%94%9F&rft.au=%E7%9F%A2%E9%87%8E%2C+%E6%99%BA%E5%BD%A6&rft.date=1984-10-01&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%8B%95%E8%84%88%E7%A1%AC%E5%8C%96%E5%AD%A6%E4%BC%9A&rft.issn=0386-2682&rft.eissn=2185-8284&rft.volume=12&rft.issue=4&rft.spage=1007&rft.epage=1012&rft_id=info:doi/10.5551%2Fjat1973.12.4_1007&rft.externalDocID=article_jat1973_12_4_12_4_1007_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0386-2682&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0386-2682&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0386-2682&client=summon